Pharmaceutical Supply of Bupivacaine and Epinephrine Injection

The contract is for the supply of sterile injectable pharmaceuticals, specifically Bupivacaine and Epinephrine Injection, in packaging that complies with FDA, USP, and DLA standards for hazardous medical materials. The requirement is issued as a subcontract under the NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. All delivered products must meet stringent regulatory and safety criteria to ensure patient safety and handling compliance, particularly given the hazardous nature of the materials. Performance of the contract is specified to occur at FPO with a ZIP code of 09583, aligning with military logistics and deployment needs. The solicitation was posted on August 4, 2026, with a firm response deadline of August 10, 2026, indicating a rapid acquisition timeline typical for critical medical supply needs. The contract is accessible via the DIBBS platform using the reference number SPE2DP26T4478, and all submissions must adhere to the established regulatory frameworks governing sterile injectables, packaging integrity, transportation, and documentation for defense and military medical use. There is no set-aside designation specified, meaning the opportunity is open to all qualified suppliers without restriction based on small business or other categories.